MX2010011370A - Inhibidores de fosfatidilinositol 3-cinasa. - Google Patents

Inhibidores de fosfatidilinositol 3-cinasa.

Info

Publication number
MX2010011370A
MX2010011370A MX2010011370A MX2010011370A MX2010011370A MX 2010011370 A MX2010011370 A MX 2010011370A MX 2010011370 A MX2010011370 A MX 2010011370A MX 2010011370 A MX2010011370 A MX 2010011370A MX 2010011370 A MX2010011370 A MX 2010011370A
Authority
MX
Mexico
Prior art keywords
compound
pharmaceutically acceptable
acceptable salt
disease
compounds
Prior art date
Application number
MX2010011370A
Other languages
English (en)
Spanish (es)
Inventor
David Messersmith
Mark Cornebise
Arnaud Le Tiran
Alexander Aronov
Tiansheng Wang
Valerie Marone
Kevin Cottrell
Francois Maltais
Mark Ledoboer
Jon H Come
Gabriel Martinez Botela
Original Assignee
Vertex Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vertex Pharma filed Critical Vertex Pharma
Publication of MX2010011370A publication Critical patent/MX2010011370A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MX2010011370A 2008-04-16 2009-04-14 Inhibidores de fosfatidilinositol 3-cinasa. MX2010011370A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4546108P 2008-04-16 2008-04-16
US10289408P 2008-10-06 2008-10-06
PCT/US2009/040454 WO2009129211A1 (en) 2008-04-16 2009-04-14 Inhibitors of phosphatidylinositol 3-kinase

Publications (1)

Publication Number Publication Date
MX2010011370A true MX2010011370A (es) 2010-12-15

Family

ID=40833464

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010011370A MX2010011370A (es) 2008-04-16 2009-04-14 Inhibidores de fosfatidilinositol 3-cinasa.

Country Status (9)

Country Link
US (1) US20110135603A1 (enExample)
EP (1) EP2283013A1 (enExample)
JP (1) JP2011518168A (enExample)
CN (1) CN102083826A (enExample)
AU (1) AU2009236380A1 (enExample)
CA (1) CA2721434A1 (enExample)
MX (1) MX2010011370A (enExample)
NZ (1) NZ588700A (enExample)
WO (1) WO2009129211A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2183232B1 (en) 2007-08-02 2013-03-06 Amgen, Inc Pi3 kinase modulators and methods of use
KR20110031419A (ko) * 2008-06-04 2011-03-28 아스트라제네카 아베 항박테리아제로서의 티아졸로［５,４­ｂ］피리딘 및 옥사졸로［５,４­ｂ］피리딘 유도체
EP2401273A1 (en) 2009-02-27 2012-01-04 Vertex Pharmaceuticals Incorporated Tri-cyclic pyrazolopyridine kinase inhibitors
WO2011049625A1 (en) 2009-10-20 2011-04-28 Mansour Samadpour Method for aflatoxin screening of products
PT2496567T (pt) 2009-11-05 2017-11-15 Rhizen Pharmaceuticals S A Novos moduladores de quinase benzopiran
KR101992311B1 (ko) 2011-05-04 2019-09-27 리젠 파마슈티컬스 소시에떼 아노님 단백질 키나아제의 조절제로서 신규한 화합물
KR101988079B1 (ko) 2012-07-04 2019-06-11 리젠 파마슈티컬스 소시에떼 아노님 선택적 pi3k 델타 억제제
CN104402875A (zh) * 2014-12-25 2015-03-11 西安山川医药科技有限公司 N-(2-氨基乙基)-n′-(6-取代-2-苯并噻唑基)脲及其盐类化合物的合成方法和用途
WO2025165930A1 (en) * 2024-01-31 2025-08-07 Biogen Ma Inc. Methods for treating spinal muscular atrophy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20070978A1 (es) * 2006-02-14 2007-11-15 Novartis Ag COMPUESTOS HETEROCICLICOS COMO INHIBIDORES DE FOSFATIDILINOSITOL 3-QUINASAS (PI3Ks)
WO2008025821A1 (en) 2006-08-30 2008-03-06 Cellzome Limited Triazole derivatives as kinase inhibitors
MX2010000716A (es) * 2007-07-18 2010-03-26 Novartis Ag Compuestos de heteroarilo biciclicos y su uso como inhibidores de cinasa.
EP2183232B1 (en) * 2007-08-02 2013-03-06 Amgen, Inc Pi3 kinase modulators and methods of use

Also Published As

Publication number Publication date
WO2009129211A1 (en) 2009-10-22
JP2011518168A (ja) 2011-06-23
AU2009236380A1 (en) 2009-10-22
US20110135603A1 (en) 2011-06-09
CN102083826A (zh) 2011-06-01
NZ588700A (en) 2012-07-27
EP2283013A1 (en) 2011-02-16
CA2721434A1 (en) 2009-10-22

Similar Documents

Publication Publication Date Title
AU2010341573B2 (en) Isoindolinone inhibitors of phosphatidylinositol 3-kinase
AU2007290359B2 (en) 5- (2-furyl)-1, 3-thiazole derivatives useful as inhibitors of phosphatidylinositol 3-kinase
US8344153B2 (en) Inhibitors of phosphatidylinositol 3-kinase
MX2010011370A (es) Inhibidores de fosfatidilinositol 3-cinasa.
EP2032562B1 (en) Selective inhibitors of rock protein kinase and uses thereof
US8481538B2 (en) Heterocyclic inhibitors of c-Met and uses thereof
KR20080080584A (ko) ｃ-Ｍｅｔ의 억제제 및 이의 용도
KR20070095952A (ko) 염증성 질환, 증식성 질환 및 면역학적으로 매개된 질환치료용 Ｔｅｃ 계열 단백질 키나제의 억제제로서 유용한피리드-2-온
MXPA05006478A (es) Triazolopiridazinas como inhibidores de proteinas cinasas.
AU2010250055A1 (en) Tri-cyclic pyrazolopyridine kinase inhibitors
JP2010510216A (ja) プロテインキナーゼのインヒビターとして有用な化合物
AU2010216219A1 (en) Tetrahydrothiazolopyridine inhibitors of phosphatidylinositol 3-kinase
US20110081316A1 (en) Pyrazole inhibitors of phosphatidylinositol 3-kinase
HK1155440A (en) Inhibitors of phosphatidylinositol 3-kinase
HK1133873A (en) 5-(2-furyl)-1, 3-thiazole derivatives useful as inhibitors of phosphatidylinositol 3-kinase
HK1120503A (en) Thiazole derivatives and use thereof

Legal Events

Date Code Title Description
FA Abandonment or withdrawal